CHRIS S MCCAULEY

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology TABOR CITY, NC NPI 1356315212

General Payments — all program years on this page

$4,378.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 181
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $705.30 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $705.3019

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $236.807
INTUITIVE SURGICAL, INC. $177.472
Novo Nordisk AS $133.752
Sumitomo Pharma America, Inc. $59.792
Lilly USA, LLC $34.822
Exact Sciences Corporation $33.222
ABBVIE INC. $17.311
Organon LLC $12.141

By program year

Program yearAmountRecords
2018 $432.8518
2019 $752.2731
2020 $683.5330
2021 $763.6042
2022 $512.1226
2023 $528.3615
2024 $705.3019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096807532 Novo Nordisk Inc $118.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096905551 Novo Nordisk Inc $15.75 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104995047 ABBVIE INC. $17.31 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114779565 Exact Sciences Corporation $15.30 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114779571 Exact Sciences Corporation $17.92 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136094193 Lilly USA, LLC $13.46 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136106345 Lilly USA, LLC $21.36 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136312855 Organon Llc $12.14 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137115139 INTUITIVE SURGICAL, INC. $69.52 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137212197 INTUITIVE SURGICAL, INC. $107.95 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139273184 Astellas Pharma US Inc $20.50 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139275610 Astellas Pharma US Inc $10.46 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139297580 Astellas Pharma US Inc $23.78 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139338932 Astellas Pharma US Inc $17.01 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139374961 Astellas Pharma US Inc $21.70 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139423487 Astellas Pharma US Inc $18.35 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139448770 Astellas Pharma US Inc $125.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148888057 Sumitomo Pharma America, Inc. $31.79 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148888059 Sumitomo Pharma America, Inc. $28.00 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.